Literature DB >> 28249286

Impact of Fibroblast Growth Factors 19 and 21 in Bariatric Metabolism.

Ashley Patton1, Farooq H Khan, Rohit Kohli.   

Abstract

BACKGROUND: Bariatric surgery is a popular and effective therapeutic intervention for obesity, which is an abnormal health condition that is prevalent worldwide. Metabolic improvements that precede weight loss after bariatric surgery may be mediated, in part, through the fibroblast growth factor (FGF) 15/19 and FGF21 signaling pathways. Both FGF15/19 and FGF21 are hormone-like members of the FGF family and exert their metabolic effects in an endocrine manner. Enhanced bile acid recycling after bariatric surgery leads to increased circulating levels of FGF15/19 in the distal small intestine. Synthesis of FGF21 is upregulated predominately in the fasting state through peroxisome proliferator-activated receptor pathways and to a lesser extent by FGF15/19. Key Messages: The biological functions of FGF15/19 and FGF21 are diverse and complicated. The tissue targeted effects of FGF15/19 and FGF21 of importance after bariatric surgery include the regulation of hepatic bile acid biosynthesis and ketogenesis as well as thermogenesis in adipose tissue, respectively. Furthermore, FGF15/19 and FGF21 function to regulate carbohydrate and lipid metabolism.
CONCLUSION: The long-term effects of bariatric surgery on weight loss are undisputable. However, the mechanism for improvements in glucose and lipid homeostasis observed shortly after bariatric surgery is less understood. This review article attempts to describe the known metabolic effects of FGF15/19 and FGF21 that may potentiate these improvements after bariatric surgery.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28249286      PMCID: PMC6372241          DOI: 10.1159/000450910

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  5 in total

Review 1.  Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  Ali Saeed; Robin P F Dullaart; Tim C M A Schreuder; Hans Blokzijl; Klaas Nico Faber
Journal:  Nutrients       Date:  2017-12-29       Impact factor: 5.717

2.  Ileal Transposition Surgery Decreases Fat Mass and Improves Glucose Metabolism in Diabetic GK Rats: Possible Involvement of FGF21.

Authors:  Kemin Yan; Weijie Chen; Huijuan Zhu; Guole Lin; Hui Pan; Naishi Li; Linjie Wang; Hongbo Yang; Meijuan Liu; Fengying Gong
Journal:  Front Physiol       Date:  2018-03-09       Impact factor: 4.566

3.  Interactions Between the Gravitostat and the Fibroblast Growth Factor System for the Regulation of Body Weight.

Authors:  Vilborg Palsdottir; Sara H Windahl; Daniel A Hägg; Hanna Keantar; Jakob Bellman; Andrew Buchanan; Tristan J Vaughan; Daniel Lindén; John-Olov Jansson; Claes Ohlsson
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

4.  Transient postprandial increase in intact circulating fibroblast growth factor-21 levels after Roux-en-Y gastric bypass: a randomized controlled clinical trial.

Authors:  Mette S Nielsen; Susanna Søberg; Julie B Schmidt; Anne Chenchar; Anders Sjödin; Matthew P Gillum
Journal:  PeerJ       Date:  2021-04-14       Impact factor: 2.984

Review 5.  Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms.

Authors:  Yu Ji; Hangil Lee; Shawn Kaura; James Yip; Hao Sun; Longfei Guan; Wei Han; Yuchuan Ding
Journal:  Biomolecules       Date:  2021-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.